Ding Zhuo-lin
Abstract
GLP-1 is a kind of incretin for treating type 2 diabetes,which has provided us with new ideas for treatment of diabetes. Liraglutide is one of the most important,and the latest clinical studies of international expansion about liraglutide has been reviewed in the paper.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
GLP-1 is a kind of incretin for treating type 2 diabetes,which has provided us with new ideas for treatment of diabetes. Liraglutide is one of the most important,and the latest clinical studies of international expansion about liraglutide has been reviewed in the paper.
Key concepts: Liraglutide, Type 2 diabetes, Incretin, Medicine, Diabetes mellitus, Diabetes treatment, Intensive care medicine, Internal medicine